Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations

Antzeko izenburuak

• High frequencies of SF3B1 and JAK2 mutations in refractory anemia with ring sideroblasts associated with marked thrombocytosis strengthen the assignment to the category of myelodysplastic/myeloproliferative neoplasms
  nork: Jeromin, Sabine, et al.
  Argitaratua: (2013)
• Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia
  nork: Meggendorfer, Manja, et al.
  Argitaratua: (2014)
• Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis
  nork: Flach, Johanna, et al.
  Argitaratua: (2010)
• Molecular characterization of AML with RUNX1-RUNX1T1 at diagnosis and relapse reveals net loss of co-mutations
  nork: Alexander Höllein, et al.
  Argitaratua: (2019-02-01)
• Molecular characterization of AML with RUNX1-RUNX1T1 at diagnosis and relapse reveals net loss of co-mutations
  nork: Höllein, Alexander, et al.
  Argitaratua: (2019)